BNET Industries
Market Cap:$22.6M
- Public
- US
Dow Jones Description
Transdel Pharmaceuticals, Inc. is a specialty pharmaceutical company developing non-invasive, topically-delivered medications. The Company's innovative patented proprietary Transdel cream formulation technology is designed to facilitate the effective penetration of drugs through the tough skin barrier to reach the target underlying tissues. In the case of Ketotransdel , the Transdel cream allows the active ingredient ketoprofen, a non steroidal anti-inflammatory drug, to reach the target soft tissue and exert its well-known anti-inflammatory and analgesic effects. The Company is also investigating other drug candidates and treatments for transdermal delivery using the Transdel platform technology for products in pain management and other therapeutic areas and for cosmetic/cosmeceutical products.
Number of Employees 3
Contact Information
4225 Executive Sq Ste 460
La Jolla, California 92037
(858) 457-5300
Peer Companies
NAICS Code Gold Ore Mining: 212221
Recent Events
-
Transdel Pharmaceuticals names new chief medical officer
-
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel
-
Transdel Pharma - Poised For Gain Or Pain?
-
Transdel Pharmaceuticals enters into license agreement with JH Direct



